نتائج البحث

1

Abstract P2-12-02: Quality of life data of breast cancer patients receiving a fixed combination of netupitant/palonosetron (NEPA) for prevention of chemotherapy-induced nausea and vomiting - A real life study

المؤلفون: Jörg Schilling, Eberhard Müller, Steffi Busch, Andrea Stefek, Martin Holländer, Meinolf Karthaus, Jürgen Schwickerath, Falk Altmann

المصدر: Cancer Research. 80:P2-12

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::74f0a62f3eece99612aad878615f315cTest
https://doi.org/10.1158/1538-7445.sabcs19-p2-12-02Test

2

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial

المصدر: Cancer Discovery. 11:1688-1699

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1424dccde96535f9934857a18f812dddTest
https://doi.org/10.1158/2159-8290.cd-20-1598Test

3

Abstract PS11-28: Efficacy and safety of entrectinib in NTRK fusion-positive (NTRK-fp) breast cancer

المؤلفون: Janice Lu, Todd M. Bauer, Minal A. Barve, S. Osborne, Filippo de Braud, Tira Tan, Christophe Le Tourneau, B. Simmons, Alexander I. Spira, Samuel McCallum, Collin M. Blakely, Saiama N. Waqar, David S. Hong

المصدر: Cancer Research. 81:PS11-28

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, education.field_of_study, business.industry, Nausea, Population, Cancer, Entrectinib, medicine.disease, Dysgeusia, Clinical trial, Breast cancer, Internal medicine, medicine, medicine.symptom, education, business, Adverse effect

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0ae546216f14ee52b79ce203d5eab059Test
https://doi.org/10.1158/1538-7445.sabcs20-ps11-28Test

4

Abstract PS9-61: Incidence of intravenous (IV) hydration post anthracycline-cyclophosphamide (AC) chemotherapy in breast cancer patients

المؤلفون: Michael C. Mosier, Rudolph M. Navari

المصدر: Cancer Research. 81:PS9-61

مصطلحات موضوعية: Cancer Research, Chemotherapy, medicine.medical_specialty, Antiemetic Agent, business.industry, medicine.drug_class, Nausea, medicine.medical_treatment, Palonosetron, medicine.disease, Ondansetron, Regimen, Breast cancer, Oncology, Internal medicine, medicine, Antiemetic, medicine.symptom, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::87d6a3de0dcb017a544f79cbaa865055Test
https://doi.org/10.1158/1538-7445.sabcs20-ps9-61Test

5

Abstract PS10-32: Patient reported outcomes (PROs) with poly(ADP-ribose) polymerase inhibitors (PARPi) versus chemotherapy (CTX) in patients (pts) with germline BRCA1/2 mutated (gBRCA1/2mut) HER2- advanced breast cancer (ABC): Results from a multi-country real-world (RW) study

المؤلفون: Katie Lewis, A. Niyazov, Bhakti Arondekar, Reshma Mahtani, Michael P. Lux, James Pike, Alex Rider

المصدر: Cancer Research. 81:PS10-32

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7444e5a0ea27ea61d1ee57bbf0059520Test
https://doi.org/10.1158/1538-7445.sabcs20-ps10-32Test

6

Abstract PS13-35: Evaluation of age as a risk factor for CINV in breast cancer patients: Post-hoc analysis of the German real-world AkyPRO study

المؤلفون: Angelika Till, Steffi Busch, Gabriele Kaltenecker, Thomas Resch, Martin Hollaender, Eberhard Müller, Joerg Peter Schilling, Meinholf Karthaus

المصدر: Cancer Research. 81:PS13-35

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.drug_class, Nausea, Palonosetron, Cancer, medicine.disease, chemistry.chemical_compound, Breast cancer, chemistry, Internal medicine, Vomiting, Netupitant, Medicine, Antiemetic, medicine.symptom, Risk factor, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e6d587dfe0e5efed1f7df9f886d84643Test
https://doi.org/10.1158/1538-7445.sabcs20-ps13-35Test

7

Abstract PS10-26: An initial safety study of gedatolisib plus cofetuzumab pelidotin for metastatic triple-negative breast cancer

المؤلفون: Tarah J. Ballinger, Kathy D. Miller, Anna Maria Storniolo, Bradley A. Hancock, Jeffrey P. Solzak, Milan Radovich, Sunil Badve, Bryan P. Schneider

المصدر: Cancer Research. 81:PS10-26

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Nausea, business.industry, Cancer, Phases of clinical research, Neutropenia, medicine.disease, Breast cancer, Internal medicine, Cohort, medicine, Mucositis, medicine.symptom, business, Triple-negative breast cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b8774e6352702e41e83b10c798a81c47Test
https://doi.org/10.1158/1538-7445.sabcs20-ps10-26Test

8

Abstract PS11-06: Efficacy and safety of larotrectinib in patients with TRK fusion breast cancer

المؤلفون: Alexander Drilon, Ezra Y. Rosen, Laura Dima, Dejan Juric, Antoine Italiano, N. Brega, John A. Reeves

المصدر: Cancer Research. 81:PS11-06

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Nausea, Phases of clinical research, Cancer, medicine.disease, Breast cancer, Internal medicine, Trk receptor, medicine, medicine.symptom, Adverse effect, business, Progressive disease, Brain metastasis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::40ac6aaf756f67e533513ef7e7f17056Test
https://doi.org/10.1158/1538-7445.sabcs20-ps11-06Test

9

FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase–zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer

المصدر: Clinical Cancer Research. 27:2126-2129

مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, Nausea, Injections, Subcutaneous, medicine.medical_treatment, Hyaluronoglucosaminidase, Breast Neoplasms, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, 03 medical and health sciences, Subcutaneous injection, 0302 clinical medicine, Breast cancer, Trastuzumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Multicenter Studies as Topic, Medicine, skin and connective tissue diseases, Drug Approval, Aged, Randomized Controlled Trials as Topic, Aged, 80 and over, Chemotherapy, United States Food and Drug Administration, business.industry, Middle Aged, medicine.disease, Metastatic breast cancer, Neoadjuvant Therapy, United States, Treatment Outcome, 030104 developmental biology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Pertuzumab, medicine.symptom, business, medicine.drug, Companion diagnostic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18c57f455dc4868e9aabb2f65a210994Test
https://doi.org/10.1158/1078-0432.ccr-20-3474Test

10

Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

المصدر: Clin Cancer Res

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Nausea, medicine.medical_treatment, Lipopolysaccharide Receptors, Breast Neoplasms, Receptor, Macrophage Colony-Stimulating Factor, Asymptomatic, Gastroenterology, Article, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Internal medicine, medicine, Humans, Immunologic Factors, Neoplasm Metastasis, Adverse effect, Aged, Cell Proliferation, Neoplasm Staging, Aged, 80 and over, biology, business.industry, Receptors, IgG, Antibodies, Monoclonal, Immunosuppression, Middle Aged, medicine.disease, Metastatic breast cancer, Clinical trial, Prostatic Neoplasms, Castration-Resistant, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, biology.protein, Female, Creatine kinase, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448fc06501a6592a9a8ac8ca34449998Test
https://doi.org/10.1158/1078-0432.ccr-20-0855Test

تنقيح النتائج